Tus kws kho mob
P19-22 Medical Policy Updates: Coupe Health and Self-Funded Benefit Plans Managed by Blue Cross and Blue Shield of Alabama
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 01, 2022
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 1821 - 1830 ntawm 3685
Tus kws kho mob
2022 April Bulletins
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 01, 2022
Cov Txiaj Ntsig thiab Kev Duav Roos
Blue Plus 2022 Formulary
Tus kws kho mob
Tavneos™ (avacopan) - Commercial
Prior Authorization, Quantity Limit
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 01, 2024
Tus kws kho mob
Xhance® (fluticasone propionate) - Commercial
Prior Authorization, Quantity Limit
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 01, 2025
Tus kws kho mob
VMAT2 Inhibitors (Vesicular Monoamine Transporter 2) - Medicaid - Effective Date 03/01/2025
Prior Authorization, Quantity Limit
Hnub Tim pib siv tau lub khoos kas: Lub Peb Hlis Ntuj Tim 01, 2025
Tus kws kho mob
P23-22 eviCore Healthcare Specialty Utilization Management (UM) Program - Cardiology and Radiology Clinical Guideline Updates
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 01, 2022
Tus kws kho mob
P24-22 Update: eviCore Healthcare Specialty Utilization Management (UM) Program – Medical Oncology Drug Prior Authorization Updates
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 01, 2022
Tus kws kho mob
QP29-22 MHCP Pharmacy Benefit Update – New drug-related Prior Authorization (PA) with Quantity Limit (QL) Criteria: TavneosTM (avacopan)
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 13, 2022
Tus kws kho mob
QP30-22 MHCP Pharmacy Benefit Update – New drug-related Prior Authorization (PA) with Quantity Limit (QL) Criteria: TyrvayaTM (varenicline)
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 13, 2022